Ignite Creation Date:
2024-05-06 @ 2:25 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04318041
Status:
RECRUITING
Last Update Posted:
2023-11-22
First Post:
2020-03-16
Brief Title:
Evaluation of the Structural Modification Effect of Diacerein Artrodar in Knee Osteoarthritic Patients
Sponsor:
TRB Chemedica
Organization:
TRB Chemedica
Study Overview
Official Title:
Evaluation of the Structural Modification Effect of Diacerein Artrodar in Knee Osteoarthritic Patients
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the structure-modifying effect of Diacerein Artrodar in knee osteoarthritic OA patients by measuring total cartilage volume from magnetic resonance imaging MRI of the knee Half of participants will receive Diacerein Artrodar while the other half will receive a placebo
Detailed Description:
Diacerein Artrodar participants take 1x1 with evening meal for 1 month D1-D28 then 1x2 with morning and evening meal for 23 months D29-end of study Placebo participants take 1x1 with evening meal for 1 month D1-D28 then 1x2 with morning and evening meal for 23 months D29-end of study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None